Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A circular RNA overcomes acquired resistance to BET inhibitors by antagonizing IGF2BP2-mediated c-MYC translation in TNBC. | Proc Natl Acad Sci U S A | 2025 | 40591591 | PubTator, text mining | PubMed |
| The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer. | Genes Dis | 2025 | 40584294 | PubTator, text mining | PubMed |
| circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing NACC1 mRNA stability. | Gastroenterol Rep (Oxf) | 2025 | 40584151 | PubTator, text mining | PubMed |
| Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA. | World J Gastroenterol | 2025 | 40538514 | PubTator, text mining | PubMed |
| H3K36me3-Guided m6A Modification of Oncogenic L1CAM-AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2025 | 40536332 | PubTator, text mining | PubMed |
| Cefiderocol "under siege"? Understanding the rise of NDM-mediated resistance to novel agents. | Chem Sci | 2025 | 40510314 | PubTator, text mining | PubMed |
| Identification of Lung Adenocarcinoma Subtypes Using Growth Hormone-Releasing Hormone-Related Genes and Establishment of Signature to Predict Prognosis and Guide Immunotherapy. | J Environ Pathol Toxicol Oncol | 2025 | 40493898 | PubTator, text mining | PubMed |
| The rise and global spread of IMP carbapenemases (1996-2023): a genomic epidemiology study. | medRxiv | 2025 | 40492084 | PubTator, text mining | PubMed |
| Multi-omics exploration of CAV1+ tumor epithelial subcelltype in oral squamous cell carcinoma and its impact on the immune microenvironment. | Discov Oncol | 2025 | 40471478 | PubTator, text mining | PubMed |
| WTAP Mediated m6A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 40470706 | PubTator, text mining | PubMed |
| A novel mechanism of radiation-induced lung injury: METTL3 mediates fibrogenesis through N6-methyladenosine modification of YY1. | J Transl Med | 2025 | 40468363 | PubTator, text mining | PubMed |
| RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma. | Nat Cancer | 2025 | 40467995 | PubTator, text mining | PubMed |
| VIRMA Accelerates the Tumorigenesis of Prostate Cancer via Regulating the m6A Modification of NSMCE2 to Eliminate the Generation of Reactive Oxygen Species. | Int J Urol | 2025 | 40459180 | PubTator, text mining | PubMed |
| The role of non-coding RNA regulates stem cell programmed death in disease therapy. | Noncoding RNA Res | 2025 | 40454168 | PubTator, text mining | PubMed |
| Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer. | Cancer Med | 2025 | 40448344 | PubTator, text mining | PubMed |
| CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p/TRAK2 axis and by reducing the stability of m6A-modified ACSBG1 mRNA. | BMC Cancer | 2025 | 40448098 | PubTator, text mining | PubMed |
| IGF2BP1 restricts the induction of human primordial germ cell fate in an m6A-dependent manner. | Cell Stem Cell | 2025 | 40436019 | PubTator, text mining | PubMed |
| Defining lung adenocarcinoma subtypes with glucocorticoid-related genes and constructing a prognostic index for immunotherapy guidance. | J Thorac Dis | 2025 | 40400930 | PubTator, text mining | PubMed |
| RegRNA 3.0: expanding regulatory RNA analysis with new features for motif, interaction, and annotation. | Nucleic Acids Res | 2025 | 40396374 | PubTator, text mining | PubMed |
| Impacts of Circular RNAs on the Osteogenic Differentiation of Dental Stem Cells. | Stem Cells Int | 2025 | 40376229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=11